Skip to main content

Search UC San Diego Today

Keyword is required

Your search for “MIS-C” returned 7 results

Kids With MIS-C Mount Normal T Cell Response to COVID-19

UC San Diego study suggests multisystem inflammatory syndrome in children (MIS-C), a rare condition associated with COVID-19, is not caused by abnormal T cell response to COVID-19 virus as previously hypothesized.

COVID-19, MIS-C and Kawasaki Disease Share Same Immune Response

COVID-19, MIS-C and KD all share a similar underlying mechanism involving the over-activation of particular inflammatory pathways, UC San Diego study shows. Findings support novel drug targets for MIS-C.

How to Tell the Difference between Kawasaki Disease and MIS-C

A national team of scientists, led by researchers at UC San Diego, have created a machine-learning algorithm for diagnosing both MIS-C and Kawasaki disease, two similar pediatric inflammatory conditions with different treatments.

Same Treatment Tested for Kids with Kawasaki Disease and Rare COVID-19 Reaction

Researchers at University of California San Diego School of Medicine tested the same treatment for kids with Kawasaki disease and rare COVID-19 reaction.

Kawasaki Disease is not a Homogenous Disease nor are its Triggers

Researchers at UC San Diego report that while Kawasaki disease occurs in clusters, the traits, and thus the triggers of the inflammatory disease vary among clusters.

UC San Diego and Rady Children’s Hospital Join Nationwide Long-COVID Study

Researchers at University of California San Diego School of Medicine and Rady Children’s Hospital-San Diego have joined a nationwide study to better understand the long-term impact of COVID-19 on patients in the United States across all demographic groups.

An Entirely New COVID-Related Syndrome

A group of UC San Diego researchers, centered at UC San Diego’s Institute for Network Medicine, teamed up with rheumatologists at the University of Leeds in the United Kingdom to solve a medical mystery.